- Report
- October 2025
- 96 Pages
Global
From €4042EUR$4,500USD£3,453GBP
- Report
- February 2026
- 250 Pages
Global
From €4033EUR$4,490USD£3,445GBP
- Report
- February 2026
- 250 Pages
Global
From €4033EUR$4,490USD£3,445GBP
- Report
- February 2026
- 250 Pages
Global
From €4033EUR$4,490USD£3,445GBP
- Report
- August 2026
- 452 Pages
Global
From €5254EUR$5,850USD£4,488GBP
- Report
- August 2026
- 187 Pages
Global
From €3184EUR$3,545USD£2,720GBP
€3538EUR$3,939USD£3,022GBP
- Report
- February 2026
- 250 Pages
Global
From €4033EUR$4,490USD£3,445GBP
- Report
- February 2026
- 250 Pages
Global
From €4033EUR$4,490USD£3,445GBP
- Report
- August 2026
- 566 Pages
Global
From €5254EUR$5,850USD£4,488GBP
- Report
- May 2026
- 400 Pages
Global
From €4445EUR$4,949USD£3,797GBP
- Report
- October 2025
- 160 Pages
Global
From €2838EUR$3,160USD£2,424GBP
€3548EUR$3,950USD£3,031GBP
- Report
- October 2025
- 160 Pages
Global
From €2838EUR$3,160USD£2,424GBP
€3548EUR$3,950USD£3,031GBP
- Report
- September 2025
- 150 Pages
Global
From €4356EUR$4,850USD£3,721GBP
- Report
- March 2026
- 209 Pages
Global
From €4446EUR$4,950USD£3,798GBP
- Report
- March 2026
- 107 Pages
Asia Pacific
From €3548EUR$3,950USD£3,031GBP
- Report
- March 2026
- 104 Pages
Europe
From €3548EUR$3,950USD£3,031GBP
- Report
- March 2026
- 80 Pages
Africa, Middle East
From €3099EUR$3,450USD£2,647GBP
- Report
- March 2026
- 88 Pages
North America
From €3099EUR$3,450USD£2,647GBP
- Report
- October 2023
- 145 Pages
Global
From €2829EUR$3,150USD£2,417GBP
- Report
- April 2023
- 147 Pages
Global
From €4445EUR$4,949USD£3,797GBP

Psoriatic Arthritis is a type of inflammatory arthritis that affects individuals with psoriasis, a chronic skin condition. It is a form of spondyloarthropathy, a group of inflammatory joint diseases that affect the spine and other joints. Symptoms of Psoriatic Arthritis include joint pain, stiffness, swelling, and tenderness. It can also cause fatigue, eye inflammation, and nail changes. Treatment options include non-steroidal anti-inflammatory drugs, disease-modifying antirheumatic drugs, biologic agents, and physical therapy.
The Psoriatic Arthritis market is a subset of the Allergy and Immunology market. It is a growing market, driven by the increasing prevalence of psoriasis and the need for effective treatments. The market is expected to benefit from the development of new treatments and the increasing awareness of the condition.
Companies in the Psoriatic Arthritis market include AbbVie, Amgen, Celgene, Eli Lilly, Janssen, Novartis, Pfizer, and UCB. Show Less Read more